Robert C. Hermann

Cetuximab and First-Line Taxane/Carboplatin Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the Randomized Multicenter Phase III Trial BMS099

Thomas J. Lynch, Taral Patel, Luke Dreisbach et al. · Journal of Clinical Oncology · 2010 · 448 citations

Medicine, Oncology, Pharmacology +17

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer

Jyoti D. Patel, Mark A. Socinski, Edward B. Garon et al. · Journal of Clinical Oncology · 2013 · 374 citations · Full text

Medicine, Oncology, Pharmacology +13

Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

John D. Hainsworth, Sharlene Litchy, John H. Barton et al. · Journal of Clinical Oncology · 2003 · 350 citations

Medicine, Oncology, Pharmacotherapy +11

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer

Shirin Khambata‐Ford, Christopher Harbison, Lowell L. Hart et al. · Journal of Clinical Oncology · 2010 · 268 citations · Full text

Medicine, Oncology, Pharmacology +17

Neurologic complications after total shoulder arthroplasty

Nancy M. Lynch, Robert H. Cofield, Peter L. Silbert et al. · Journal of Shoulder and Elbow Surgery · 1996 · 219 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14